Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Morgan Stanley upgrades Rentokil, downgrades DCC
(Sharecast News) - Morgan Stanley upgraded Rentokil Initial and RS Group on Tuesday, but downgraded DCC as it took a look at the European business services sector. The bank lifted Rentokil to 'overweight' from 'equalweight' and upped the price target to 520p from 450p.
It said it sees improving organic momentum in North America pest control through 2026 driving a re-rating, and scope for significant value to be unlocked over the medium term.
Morgan Stanley upgraded RS Group to 'overweight' from 'equalweight' and kept the price target at 790p. It downgraded DCC to 'equalweight' from 'overweight' and cut the price target to 5,750p from 6,150p.
"At RS Group, good progress made on costs, technology and efficiencies puts the group in a strong position to benefit from a cyclical recovery," it said. It said the stock has moved up to number 9 on its 'Best Business Model' ranking on a better organic outlook and improved cash conversion.
The bank said it was neutralising DCC to equalweight as it sees few reasons to be positive into 2026 and limited catalysts for a re-rating as the group transitions towards a pure-play energy business
In the note, Morgan Stanley said its preferred stocks for 2026 are Experian, Diploma, Rentokil, Verisure, Bureau Veritas and ISS.
At 1420 GMT, Rentokil was up 4% at 462.9p, RS Group was 1.3% higher at 643.50p and DCC was down 2% at 4,334p.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
